ORBIMED CAPITAL LLC 13D and 13G filings for Milestone Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
ORBIMED CAPITAL LLC | 0 0.000% |
-2,583,821 (Position Closed) |
Filing |
| 2022-02-11 4:32 pm Purchase |
2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
ORBIMED CAPITAL LLC | 2,583,821 8.700% |
90,712 (+3.64%) |
Filing |
| 2021-02-12 5:03 pm Purchase |
2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
ORBIMED CAPITAL LLC | 2,493,109 8.360% |
2,493,109 (New Position) |
Filing |